Article
AFD China Newsletter - June 2026
China's intellectual property landscape is undergoing significant transformation with new protections for clinical trial data, enhanced copyright enforcement in AI-generated content, and landmark Supreme Court rulings on patent jurisdiction and inventiveness. The newsletter examines how regulatory changes and judicial decisions are reshaping IP rights for pharmaceutical companies, technology platforms, and patent holders navigating complex infringement disputes.
AFD China